Apellis Pharmaceuticals buy phonebroker
Start price
18.01.18
/
50%
€17.99
Target price
22.01.18
€18.94
Performance (%)
6.26%
End price
22.01.18
€19.11
Summary
This prediction ended on 22.01.18 with a price of €19.11. With a performance of 6.26%, the BUY prediction by phonebroker for Apellis Pharmaceuticals closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 4,64 % | 7,49 % | 6,99 % | 53,73 % |
| iShares Nasdaq 100 | 4,47 % | 16,80 % | 40,28 % | 104,33 % |
| iShares Nikkei 225® | 7,67 % | 16,86 % | 47,87 % | 73,79 % |
| iShares S&P 500 | 2,47 % | 9,90 % | 28,43 % | 72,58 % |